10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

SMZ1 (Sino Biopharmaceutical Limited) Stock Analysis
Buy, Hold or Sell?

Let's analyze Sino Biopharmaceutical Limited together

I guess you are interested in Sino Biopharmaceutical Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Sino Biopharmaceutical Limited’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Sino Biopharmaceutical Limited’s Price Targets

I'm going to help you getting a better view of Sino Biopharmaceutical Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Sino Biopharmaceutical Limited

I send you an email if I find something interesting about Sino Biopharmaceutical Limited.

1. Quick Overview

1.1. Quick analysis of Sino Biopharmaceutical Limited (30 sec.)










1.2. What can you expect buying and holding a share of Sino Biopharmaceutical Limited? (30 sec.)

How much money do you get?

How much money do you get?
€0.06
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€0.28
Expected worth in 1 year
€0.41
How sure are you?
87.5%

+ What do you gain per year?

Total Gains per Share
€0.18
Return On Investment
19.4%

For what price can you sell your share?

Current Price per Share
€0.92
Expected price per share
€0.5593 - €
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Sino Biopharmaceutical Limited (5 min.)




Live pricePrice per Share (EOD)
€0.92
Intrinsic Value Per Share
€0.29 - €0.44
Total Value Per Share
€0.57 - €0.73

2.2. Growth of Sino Biopharmaceutical Limited (5 min.)




Is Sino Biopharmaceutical Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$6b$5.3b$647m10.8%

How much money is Sino Biopharmaceutical Limited making?

Current yearPrevious yearGrowGrow %
Making money$491.8m$327.7m$164.1m33.4%
Net Profit Margin12.1%8.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Sino Biopharmaceutical Limited (5 min.)




2.4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Sino Biopharmaceutical Limited?

Welcome investor! Sino Biopharmaceutical Limited's management wants to use your money to grow the business. In return you get a share of Sino Biopharmaceutical Limited.

First you should know what it really means to hold a share of Sino Biopharmaceutical Limited. And how you can make/lose money.

Speculation

The Price per Share of Sino Biopharmaceutical Limited is €0.9156. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sino Biopharmaceutical Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sino Biopharmaceutical Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.28. Based on the TTM, the Book Value Change Per Share is €0.03 per quarter. Based on the YOY, the Book Value Change Per Share is €0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sino Biopharmaceutical Limited.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps0.033.0%0.033.0%0.022.0%0.022.3%0.044.2%0.033.3%
Usd Book Value Change Per Share0.044.1%0.044.1%0.011.0%0.021.8%0.010.7%0.044.5%
Usd Dividend Per Share0.011.6%0.011.6%0.000.5%0.011.0%0.011.0%0.010.8%
Usd Total Gains Per Share0.055.7%0.055.7%0.011.5%0.032.8%0.011.6%0.055.3%
Usd Price Per Share0.46-0.46-0.45-0.52-0.63-0.70-
Price to Earnings Ratio16.95-16.95-25.45-25.34-25.21-30.02-
Price-to-Total Gains Ratio8.80-8.80-32.96-32.51-19.23-21.08-
Price to Book Ratio1.39-1.39-1.55-1.73-2.62-3.63-
Price-to-Total Gains Ratio8.80-8.80-32.96-32.51-19.23-21.08-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.07500596
Number of shares930
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.040.01
Usd Total Gains Per Share0.050.01
Gains per Quarter (930 shares)48.4313.91
Gains per Year (930 shares)193.7055.64
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
153141184332346
21062813786645102
31594225729968158
421256376613290214
5265703960165113270
63188441154198136326
73719851348231158382
842411251542264181438
947712661736297203494
1053014071930330226550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%7.01.00.087.5%7.01.00.087.5%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%7.01.00.087.5%7.01.00.087.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Sino Biopharmaceutical Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0320.0320%0.008+323%0.014+133%0.005+523%0.035-8%
Book Value Per Share--0.2810.2810%0.249+13%0.257+9%0.231+22%0.174+62%
Current Ratio--1.2621.2620%1.053+20%1.201+5%1.443-13%1.867-32%
Debt To Asset Ratio--0.3460.3460%0.400-13%0.385-10%0.411-16%0.379-9%
Debt To Equity Ratio--0.7080.7080%0.835-15%0.807-12%0.931-24%0.830-15%
Dividend Per Share--0.0120.0120%0.004+194%0.008+50%0.008+60%0.006+91%
Enterprise Value--4392663849.5494392663849.5490%4059453025.006+8%5187990440.640-15%7137772620.275-38%11118909012.595-60%
Eps--0.0230.0230%0.015+51%0.018+27%0.033-30%0.025-10%
Ev To Sales Ratio--1.2711.2710%1.294-2%1.616-21%2.318-45%4.443-71%
Free Cash Flow Per Share--0.0340.0340%0.028+21%0.031+12%0.027+26%0.025+40%
Free Cash Flow To Equity Per Share--0.0340.0340%0.028+21%0.031+12%0.027+26%0.021+61%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.444----------
Intrinsic Value_10Y_min--0.285----------
Intrinsic Value_1Y_max--0.034----------
Intrinsic Value_1Y_min--0.028----------
Intrinsic Value_3Y_max--0.109----------
Intrinsic Value_3Y_min--0.085----------
Intrinsic Value_5Y_max--0.195----------
Intrinsic Value_5Y_min--0.143----------
Market Cap--7101953529.8497101953529.8490%7104006485.2060%8148155520.540-13%10053540012.575-29%10814689700.516-34%
Net Profit Margin--0.1210.1210%0.089+36%0.103+18%0.194-37%0.190-36%
Operating Margin----0%-0%-0%0.045-100%0.132-100%
Operating Ratio--0.9620.9620%0.970-1%0.9650%0.993-3%0.996-3%
Pb Ratio3.256+57%1.3871.3870%1.555-11%1.732-20%2.619-47%3.629-62%
Pe Ratio39.789+57%16.95316.9530%25.450-33%25.344-33%25.209-33%30.020-44%
Price Per Share0.916+57%0.3900.3900%0.387+1%0.441-11%0.538-28%0.593-34%
Price To Free Cash Flow Ratio26.672+57%11.36411.3640%13.606-16%14.576-22%21.184-46%27.467-59%
Price To Total Gains Ratio20.645+57%8.7968.7960%32.964-73%32.510-73%19.227-54%21.081-58%
Quick Ratio--0.4890.4890%0.374+31%0.429+14%0.504-3%0.671-27%
Return On Assets--0.0540.0540%0.037+46%0.043+24%0.086-38%0.096-44%
Return On Equity--0.1100.1100%0.077+43%0.091+21%0.184-40%0.200-45%
Total Gains Per Share--0.0440.0440%0.012+278%0.022+102%0.013+248%0.041+7%
Usd Book Value--6011457959.7646011457959.7640%5364396415.531+12%5569477294.733+8%5032339924.753+19%4084276861.045+47%
Usd Book Value Change Per Share--0.0380.0380%0.009+323%0.016+133%0.006+523%0.041-8%
Usd Book Value Per Share--0.3300.3300%0.292+13%0.302+9%0.271+22%0.204+62%
Usd Dividend Per Share--0.0140.0140%0.005+194%0.010+50%0.009+60%0.007+91%
Usd Enterprise Value--5157426625.7555157426625.7550%4766203796.660+8%6091219576.356-15%8380458833.465-38%13054711071.688-60%
Usd Eps--0.0270.0270%0.018+51%0.021+27%0.039-30%0.030-10%
Usd Free Cash Flow--733752517.579733752517.5790%613037990.234+20%662529210.780+11%592544593.405+24%426477249.852+72%
Usd Free Cash Flow Per Share--0.0400.0400%0.033+21%0.036+12%0.032+26%0.029+40%
Usd Free Cash Flow To Equity Per Share--0.0400.0400%0.033+21%0.036+12%0.032+26%0.025+61%
Usd Market Cap--8338403639.3958338403639.3950%8340814014.2810%9566749396.666-13%11803861328.764-29%12697527177.376-34%
Usd Price Per Share1.075+57%0.4580.4580%0.455+1%0.517-11%0.632-28%0.696-34%
Usd Profit--491865865.398491865865.3980%327730170.714+50%392356259.630+25%723915886.105-32%606721134.065-19%
Usd Revenue--4056843346.6434056843346.6430%3682058914.996+10%3798871121.394+7%3699015516.082+10%3095565580.704+31%
Usd Total Gains Per Share--0.0520.0520%0.014+278%0.026+102%0.015+248%0.049+7%
 EOD+2 -4MRQTTM+0 -0YOY+32 -53Y+30 -75Y+22 -1610Y+20 -18

3.3 Fundamental Score

Let's check the fundamental score of Sino Biopharmaceutical Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1539.789
Price to Book Ratio (EOD)Between0-13.256
Net Profit Margin (MRQ)Greater than00.121
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.489
Current Ratio (MRQ)Greater than11.262
Debt to Asset Ratio (MRQ)Less than10.346
Debt to Equity Ratio (MRQ)Less than10.708
Return on Equity (MRQ)Greater than0.150.110
Return on Assets (MRQ)Greater than0.050.054
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Sino Biopharmaceutical Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.901
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Sino Biopharmaceutical Limited

  • Other
  • 21302

Sino Biopharmaceutical Limited, an investment holding company, researches and develops, produces, and sells Chinese and chemical medicines in Hong Kong, Mainland China, and internationally. The company operates in three segments: Chemical Medicines and Biopharmaceutical Medicines, Investment, and Others. Its principal products include hepatitis medicines, such as Runzhong dispersible tablets, Tianqingganmei injections, Tianding tablets, Tianqingganping enteric capsules, Mingzheng capsules, and Ganze entecavir capsules; cardio-cerebral medicines comprising Kaishi injections, Yilunping and Tuotuo tablets, Kaina tablets, and Tianqingning injections; and oncology medicines consisting of Saiweijian, Tianqingyitai, Qingweike, and Zhiruo injections, as well as Focus V and Genike capsules, and Shoufu and Yinishu tablets. The company's principal products also comprise Analgesic medicines, such as Kaifen injections and Debaian Cataplasms; Orthopedic medicines, which include Gaisanchun capsules and Jiuli tablets; digestive system medicines, such as Aisuping injections and Getai tablets; anti-infectious medicines consisting of Tiance injections and Tianjie tablets; respiratory system medicines, including Tianqingsule inhalation powder and Chia Tai Suke tablets; and parenteral nutritious medicines, such as Xinhaineng and Fenghaineng fructose injections. In addition, it is involved in the development of medicines for tumor, liver, cardio-cerebral, analgesia, respiratory system, and orthopedic diseases; property holding activities; the retail and distribution of pharmaceutical products; optometry for optical glasses and sale of ophthalmic products; the provision of medical management and healthy information services; and outpatient and surgical procedure. Further, the company manufactures, sells, and distributes health food; and develops medical technology. Sino Biopharmaceutical Limited was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

Fundamental data was last updated by Penke on 2025-09-05 00:09:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Sino Biopharmaceutical Limited earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Sino Biopharmaceutical Limited to theΒ Other industry mean.
  • A Net Profit Margin of 12.1%Β means thatΒ €0.12 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sino Biopharmaceutical Limited:

  • The MRQ is 12.1%. The company is making a huge profit. +2
  • The TTM is 12.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ12.1%TTM12.1%0.0%
TTM12.1%YOY8.9%+3.2%
TTM12.1%5Y19.4%-7.3%
5Y19.4%10Y19.0%+0.3%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ12.1%6.2%+5.9%
TTM12.1%5.8%+6.3%
YOY8.9%5.8%+3.1%
3Y10.3%5.9%+4.4%
5Y19.4%6.0%+13.4%
10Y19.0%5.8%+13.2%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Sino Biopharmaceutical Limited is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Sino Biopharmaceutical Limited to theΒ Other industry mean.
  • 5.4% Return on Assets means thatΒ Sino Biopharmaceutical Limited generatedΒ €0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sino Biopharmaceutical Limited:

  • The MRQ is 5.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.4%TTM5.4%0.0%
TTM5.4%YOY3.7%+1.7%
TTM5.4%5Y8.6%-3.2%
5Y8.6%10Y9.6%-1.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4%1.3%+4.1%
TTM5.4%1.2%+4.2%
YOY3.7%1.1%+2.6%
3Y4.3%1.1%+3.2%
5Y8.6%1.3%+7.3%
10Y9.6%1.3%+8.3%
4.3.1.3. Return on Equity

Shows how efficient Sino Biopharmaceutical Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Sino Biopharmaceutical Limited to theΒ Other industry mean.
  • 11.0% Return on Equity means Sino Biopharmaceutical Limited generated €0.11Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sino Biopharmaceutical Limited:

  • The MRQ is 11.0%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 11.0%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.0%TTM11.0%0.0%
TTM11.0%YOY7.7%+3.3%
TTM11.0%5Y18.4%-7.4%
5Y18.4%10Y20.0%-1.6%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ11.0%3.8%+7.2%
TTM11.0%3.6%+7.4%
YOY7.7%3.4%+4.3%
3Y9.1%3.4%+5.7%
5Y18.4%3.6%+14.8%
10Y20.0%3.7%+16.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Sino Biopharmaceutical Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Sino Biopharmaceutical Limited is operatingΒ .

  • Measures how much profit Sino Biopharmaceutical Limited makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Sino Biopharmaceutical Limited to theΒ Other industry mean.
  • An Operating Margin of 0.0%Β means the company generated €0.00 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sino Biopharmaceutical Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y4.5%-4.5%
5Y4.5%10Y13.2%-8.7%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.8%-11.8%
TTM-5.8%-5.8%
YOY-3.0%-3.0%
3Y-2.3%-2.3%
5Y4.5%1.9%+2.6%
10Y13.2%5.8%+7.4%
4.3.2.2. Operating Ratio

Measures how efficient Sino Biopharmaceutical Limited is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Other industry mean).
  • An Operation Ratio of 0.96 means that the operating costs are €0.96 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Sino Biopharmaceutical Limited:

  • The MRQ is 0.962. The company is less efficient in keeping operating costs low.
  • The TTM is 0.962. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.962TTM0.9620.000
TTM0.962YOY0.970-0.007
TTM0.9625Y0.993-0.031
5Y0.99310Y0.996-0.002
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9621.224-0.262
TTM0.9621.200-0.238
YOY0.9701.265-0.295
3Y0.9651.257-0.292
5Y0.9931.248-0.255
10Y0.9961.288-0.292
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Sino Biopharmaceutical Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Sino Biopharmaceutical Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Other industry mean).
  • A Current Ratio of 1.26Β means the company has €1.26 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Sino Biopharmaceutical Limited:

  • The MRQ is 1.262. The company is just able to pay all its short-term debts.
  • The TTM is 1.262. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.262TTM1.2620.000
TTM1.262YOY1.053+0.209
TTM1.2625Y1.443-0.181
5Y1.44310Y1.867-0.424
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2621.394-0.132
TTM1.2621.402-0.140
YOY1.0531.436-0.383
3Y1.2011.505-0.304
5Y1.4431.553-0.110
10Y1.8671.508+0.359
4.4.3.2. Quick Ratio

Measures if Sino Biopharmaceutical Limited is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Sino Biopharmaceutical Limited to theΒ Other industry mean.
  • A Quick Ratio of 0.49Β means the company can pay off €0.49 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sino Biopharmaceutical Limited:

  • The MRQ is 0.489. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.489. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.489TTM0.4890.000
TTM0.489YOY0.374+0.115
TTM0.4895Y0.504-0.015
5Y0.50410Y0.671-0.167
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4890.559-0.070
TTM0.4890.559-0.070
YOY0.3740.597-0.223
3Y0.4290.594-0.165
5Y0.5040.609-0.105
10Y0.6710.608+0.063
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Sino Biopharmaceutical Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Sino Biopharmaceutical LimitedΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Sino Biopharmaceutical Limited to Other industry mean.
  • A Debt to Asset Ratio of 0.35Β means that Sino Biopharmaceutical Limited assets areΒ financed with 34.6% credit (debt) and the remaining percentage (100% - 34.6%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Sino Biopharmaceutical Limited:

  • The MRQ is 0.346. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.346. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.346TTM0.3460.000
TTM0.346YOY0.400-0.054
TTM0.3465Y0.411-0.065
5Y0.41110Y0.379+0.032
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3460.523-0.177
TTM0.3460.519-0.173
YOY0.4000.531-0.131
3Y0.3850.534-0.149
5Y0.4110.544-0.133
10Y0.3790.549-0.170
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Sino Biopharmaceutical Limited is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Sino Biopharmaceutical Limited to theΒ Other industry mean.
  • A Debt to Equity ratio of 70.8% means that company has €0.71 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sino Biopharmaceutical Limited:

  • The MRQ is 0.708. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.708. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.708TTM0.7080.000
TTM0.708YOY0.835-0.126
TTM0.7085Y0.931-0.223
5Y0.93110Y0.830+0.101
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7081.038-0.330
TTM0.7081.038-0.330
YOY0.8351.118-0.283
3Y0.8071.158-0.351
5Y0.9311.232-0.301
10Y0.8301.313-0.483
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Sino Biopharmaceutical Limited generates.

  • Above 15 is considered overpriced butΒ always compareΒ Sino Biopharmaceutical Limited to theΒ Other industry mean.
  • A PE ratio of 16.95 means the investor is paying €16.95Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sino Biopharmaceutical Limited:

  • The EOD is 39.789. Based on the earnings, the company is overpriced. -1
  • The MRQ is 16.953. Based on the earnings, the company is fair priced.
  • The TTM is 16.953. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD39.789MRQ16.953+22.837
MRQ16.953TTM16.9530.000
TTM16.953YOY25.450-8.498
TTM16.9535Y25.209-8.257
5Y25.20910Y30.020-4.811
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD39.78915.827+23.962
MRQ16.95315.787+1.166
TTM16.95315.186+1.767
YOY25.45013.605+11.845
3Y25.34411.941+13.403
5Y25.20914.714+10.495
10Y30.02014.495+15.525
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sino Biopharmaceutical Limited:

  • The EOD is 26.672. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 11.364. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 11.364. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD26.672MRQ11.364+15.308
MRQ11.364TTM11.3640.000
TTM11.364YOY13.606-2.242
TTM11.3645Y21.184-9.820
5Y21.18410Y27.467-6.283
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD26.6729.208+17.464
MRQ11.3647.964+3.400
TTM11.3647.453+3.911
YOY13.6066.596+7.010
3Y14.5764.134+10.442
5Y21.1843.949+17.235
10Y27.4673.950+23.517
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Sino Biopharmaceutical Limited is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Other industry mean).
  • A PB ratio of 1.39 means the investor is paying €1.39Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Sino Biopharmaceutical Limited:

  • The EOD is 3.256. Based on the equity, the company is fair priced.
  • The MRQ is 1.387. Based on the equity, the company is underpriced. +1
  • The TTM is 1.387. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.256MRQ1.387+1.869
MRQ1.387TTM1.3870.000
TTM1.387YOY1.555-0.168
TTM1.3875Y2.619-1.232
5Y2.61910Y3.629-1.010
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD3.2561.682+1.574
MRQ1.3871.609-0.222
TTM1.3871.508-0.121
YOY1.5551.508+0.047
3Y1.7321.608+0.124
5Y2.6191.952+0.667
10Y3.6291.827+1.802
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-12-312021-12-312022-12-312023-12-312024-12-31
Net Interest Income  -15,485-2,058-17,543-10,417-27,960-8,975-36,93561,40724,472



6.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets65,408,069
Total Liabilities22,633,999
Total Stockholder Equity31,960,789
 As reported
Total Liabilities 22,633,999
Total Stockholder Equity+ 31,960,789
Total Assets = 65,408,069

Assets

Total Assets65,408,069
Total Current Assets24,685,331
Long-term Assets40,722,738
Total Current Assets
Cash And Cash Equivalents 9,569,584
Short-term Investments 5,248,327
Net Receivables 4,310,766
Inventory 2,373,145
Total Current Assets  (as reported)24,685,331
Total Current Assets  (calculated)21,501,822
+/- 3,183,509
Long-term Assets
Property Plant Equipment 10,288,156
Goodwill 915,689
Intangible Assets 2,145,277
Long-term Assets  (as reported)40,722,738
Long-term Assets  (calculated)13,349,122
+/- 27,373,616

Liabilities & Shareholders' Equity

Total Current Liabilities19,556,490
Long-term Liabilities3,077,509
Total Stockholder Equity31,960,789
Total Current Liabilities
Short Long Term Debt 7,602,068
Accounts payable 1,497,461
Other Current Liabilities 8,720
Total Current Liabilities  (as reported)19,556,490
Total Current Liabilities  (calculated)9,108,249
+/- 10,448,241
Long-term Liabilities
Long term Debt 1,996,752
Capital Lease Obligations Min Short Term Debt111,726
Long-term Liabilities Other 201,895
Long-term Liabilities  (as reported)3,077,509
Long-term Liabilities  (calculated)2,310,373
+/- 767,136
Total Stockholder Equity
Retained Earnings 25,280,560
Total Stockholder Equity (as reported)31,960,789
Total Stockholder Equity (calculated)25,280,560
+/- 6,680,229
Other
Capital Stock414,384
Common Stock Shares Outstanding 18,205,469
Net Debt 29,236
Net Invested Capital 41,559,609
Net Working Capital 5,128,841
Property Plant and Equipment Gross 16,746,955



6.3. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
> Total Assets 
9,968,867
14,163,941
16,482,618
18,391,162
20,935,339
49,780,208
58,299,251
47,210,438
60,543,337
64,064,284
63,604,819
65,408,069
65,408,06963,604,81964,064,28460,543,33747,210,43858,299,25149,780,20820,935,33918,391,16216,482,61814,163,9419,968,867
   > Total Current Assets 
5,826,891
8,180,526
9,935,731
12,732,475
13,780,119
18,538,125
24,913,095
22,794,203
23,503,178
25,934,905
23,805,531
24,685,331
24,685,33123,805,53125,934,90523,503,17822,794,20324,913,09518,538,12513,780,11912,732,4759,935,7318,180,5265,826,891
       Cash And Cash Equivalents 
2,981,343
4,468,333
2,711,061
3,763,799
4,188,140
6,676,042
11,911,210
11,259,084
10,568,812
12,066,217
9,451,878
9,569,584
9,569,5849,451,87812,066,21710,568,81211,259,08411,911,2106,676,0424,188,1403,763,7992,711,0614,468,3332,981,343
       Short-term Investments 
0
0
3,614,071
2,529,521
3,591,152
2,000,685
1,576,240
5,172,739
5,225,239
4,855,446
4,666,297
5,248,327
5,248,3274,666,2974,855,4465,225,2395,172,7391,576,2402,000,6853,591,1522,529,5213,614,07100
       Net Receivables 
1,719,032
2,124,054
2,083,080
3,091,931
2,744,791
3,865,169
2,063,232
2,248,409
3,275,154
3,722,193
3,777,417
4,310,766
4,310,7663,777,4173,722,1933,275,1542,248,4092,063,2323,865,1692,744,7913,091,9312,083,0802,124,0541,719,032
       Inventory 
805,343
901,625
950,148
895,133
918,819
1,209,160
1,658,597
1,880,051
1,937,741
2,328,844
1,993,472
2,373,145
2,373,1451,993,4722,328,8441,937,7411,880,0511,658,5971,209,160918,819895,133950,148901,625805,343
       Other Current Assets 
4,515
7,323
7,342
9,832
16,833
37,116
0
0
0
0
0
0
00000037,11616,8339,8327,3427,3234,515
   > Long-term Assets 
0
0
0
5,665,701
7,155,220
31,242,083
33,386,156
24,416,235
37,040,159
38,129,379
39,799,288
40,722,738
40,722,73839,799,28838,129,37937,040,15924,416,23533,386,15631,242,0837,155,2205,665,701000
       Property Plant Equipment 
2,107,111
2,340,180
2,656,187
2,687,355
3,483,253
5,804,369
6,976,357
8,392,204
8,516,062
9,251,183
9,912,161
10,288,156
10,288,1569,912,1619,251,1838,516,0628,392,2046,976,3575,804,3693,483,2532,687,3552,656,1872,340,1802,107,111
       Goodwill 
58,083
110,850
110,709
98,956
88,926
13,896,976
13,896,976
88,926
647,930
662,611
680,452
915,689
915,689680,452662,611647,93088,92613,896,97613,896,97688,92698,956110,709110,85058,083
       Long Term Investments 
1,261,869
1,786,984
1,851,663
1,412,087
1,778,714
1,069,609
0
0
0
0
0
0
0000001,069,6091,778,7141,412,0871,851,6631,786,9841,261,869
       Intangible Assets 
23,260
78,313
81,851
182,473
219,249
8,349,174
7,703,642
924,710
1,064,016
1,251,839
2,228,509
2,145,277
2,145,2772,228,5091,251,8391,064,016924,7107,703,6428,349,174219,249182,47381,85178,31323,260
       Long-term Assets Other 
0
0
0
0
7,155,220
31,242,083
33,386,156
0
602,175
508,261
302,673
0
0302,673508,261602,175033,386,15631,242,0837,155,2200000
> Total Liabilities 
2,743,904
5,345,645
6,039,573
7,701,900
8,324,290
12,230,684
18,014,683
24,790,880
22,814,314
26,120,736
25,434,866
22,633,999
22,633,99925,434,86626,120,73622,814,31424,790,88018,014,68312,230,6848,324,2907,701,9006,039,5735,345,6452,743,904
   > Total Current Liabilities 
2,579,870
3,861,272
5,524,052
5,656,343
5,688,451
9,668,621
8,123,025
10,943,539
15,345,019
20,150,677
22,606,775
19,556,490
19,556,49022,606,77520,150,67715,345,01910,943,5398,123,0259,668,6215,688,4515,656,3435,524,0523,861,2722,579,870
       Short-term Debt 
74,153
12,491
15,870
1,368,719
741,307
2,905,575
666,749
0
0
0
0
0
00000666,7492,905,575741,3071,368,71915,87012,49174,153
       Short Long Term Debt 
74,153
12,491
15,870
1,368,719
741,307
2,905,575
666,749
1,552,825
6,520,565
9,663,410
11,135,940
7,602,068
7,602,06811,135,9409,663,4106,520,5651,552,825666,7492,905,575741,3071,368,71915,87012,49174,153
       Accounts payable 
476,126
809,200
767,592
826,734
928,607
1,832,166
1,809,445
1,947,802
1,693,152
1,637,351
1,334,703
1,497,461
1,497,4611,334,7031,637,3511,693,1521,947,8021,809,4451,832,166928,607826,734767,592809,200476,126
       Other Current Liabilities 
528,017
828,917
1,125,532
1,067,750
1,252,828
1,678,458
0
0
0
0
12,195
8,720
8,72012,19500001,678,4581,252,8281,067,7501,125,532828,917528,017
   > Long-term Liabilities 
0
0
0
2,048,671
2,635,839
2,562,063
9,891,658
13,847,341
7,469,295
5,970,059
2,828,091
3,077,509
3,077,5092,828,0915,970,0597,469,29513,847,3419,891,6582,562,0632,635,8392,048,671000
       Capital Lease Obligations Min Short Term Debt
-74,153
-12,491
-15,870
-1,368,719
-741,307
-2,905,575
-602,400
293,560
384,422
384,694
369,882
111,726
111,726369,882384,694384,422293,560-602,400-2,905,575-741,307-1,368,719-15,870-12,491-74,153
       Long-term Liabilities Other 
0
0
0
201,492
241,912
532,941
0
0
227,983
131,076
125,460
201,895
201,895125,460131,076227,98300532,941241,912201,492000
       Deferred Long Term Liability 
64,499
83,920
117,056
118,424
164,140
504,979
0
0
0
0
0
0
000000504,979164,140118,424117,05683,92064,499
> Total Stockholder Equity
5,487,016
6,610,642
7,755,888
7,955,412
9,208,794
29,212,838
31,111,658
16,747,160
30,291,116
29,747,035
30,474,469
31,960,789
31,960,78930,474,46929,747,03530,291,11616,747,16031,111,65829,212,8389,208,7947,955,4127,755,8886,610,6425,487,016
   Common Stock
123,536
123,536
185,305
170,033
170,033
278,846
0
0
0
0
0
0
000000278,846170,033170,033185,305123,536123,536
   Retained Earnings 
3,694,432
4,887,332
6,371,086
6,753,723
8,474,884
16,810,903
0
0
23,071,400
23,069,898
23,648,943
25,280,560
25,280,56023,648,94323,069,89823,071,4000016,810,9038,474,8846,753,7236,371,0864,887,3323,694,432
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
362,861
293,587
-44,921
-169,903
-587,269
-462,850
0
0
0
0
0
0
000000-462,850-587,269-169,903-44,921293,587362,861



6.4. Balance Sheets

Currency in CNY. All numbers in thousands.




6.5. Cash Flows

Currency in CNY. All numbers in thousands.




6.6. Income Statements

Currency in CNY. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue28,866,159
Cost of Revenue-5,336,218
Gross Profit23,529,94123,529,941
 
Operating Income (+$)
Gross Profit23,529,941
Operating Expense-22,445,040
Operating Income6,421,1191,084,901
 
Operating Expense (+$)
Research Development5,089,203
Selling General Administrative12,159,476
Selling And Marketing Expenses-
Operating Expense22,445,04017,248,679
 
Net Interest Income (+$)
Interest Income499,564
Interest Expense-295,117
Other Finance Cost-0
Net Interest Income204,447
 
Pretax Income (+$)
Operating Income6,421,119
Net Interest Income204,447
Other Non-Operating Income Expenses-
Income Before Tax (EBT)5,277,4686,421,119
EBIT - interestExpense = -295,117
3,499,834
3,794,951
Interest Expense295,117
Earnings Before Interest and Taxes (EBIT)-5,572,585
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax5,277,468
Tax Provision-492,918
Net Income From Continuing Ops4,784,5504,784,550
Net Income3,499,834
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--204,447
 

Technical Analysis of Sino Biopharmaceutical Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sino Biopharmaceutical Limited. The general trend of Sino Biopharmaceutical Limited is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sino Biopharmaceutical Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Sino Biopharmaceutical Limited Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sino Biopharmaceutical Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 0.77163632905373 > 0.7664 > 0.5593.

Know someone who trades $SMZ1? Share this with them.πŸ‘‡

Sino Biopharmaceutical Limited Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sino Biopharmaceutical Limited. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sino Biopharmaceutical Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sino Biopharmaceutical Limited.

Sino Biopharmaceutical Limited Daily Moving Average Convergence/Divergence (MACD) ChartSino Biopharmaceutical Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sino Biopharmaceutical Limited. The current adx is .

Sino Biopharmaceutical Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sino Biopharmaceutical Limited.

Sino Biopharmaceutical Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sino Biopharmaceutical Limited.

Sino Biopharmaceutical Limited Daily Relative Strength Index (RSI) ChartSino Biopharmaceutical Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sino Biopharmaceutical Limited.

Sino Biopharmaceutical Limited Daily Stochastic Oscillator ChartSino Biopharmaceutical Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sino Biopharmaceutical Limited.

Sino Biopharmaceutical Limited Daily Commodity Channel Index (CCI) ChartSino Biopharmaceutical Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sino Biopharmaceutical Limited.

Sino Biopharmaceutical Limited Daily Chande Momentum Oscillator (CMO) ChartSino Biopharmaceutical Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sino Biopharmaceutical Limited.

Sino Biopharmaceutical Limited Daily Williams %R ChartSino Biopharmaceutical Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Sino Biopharmaceutical Limited.

Sino Biopharmaceutical Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sino Biopharmaceutical Limited.

Sino Biopharmaceutical Limited Daily Average True Range (ATR) ChartSino Biopharmaceutical Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sino Biopharmaceutical Limited.

Sino Biopharmaceutical Limited Daily On-Balance Volume (OBV) ChartSino Biopharmaceutical Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sino Biopharmaceutical Limited.

Sino Biopharmaceutical Limited Daily Money Flow Index (MFI) ChartSino Biopharmaceutical Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sino Biopharmaceutical Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-02STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-17ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-17STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-31MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-08-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-09STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Sino Biopharmaceutical Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sino Biopharmaceutical Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.901
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Sino Biopharmaceutical Limited with someone you think should read this too:
  • Are you bullish or bearish on Sino Biopharmaceutical Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sino Biopharmaceutical Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sino Biopharmaceutical Limited

I send you an email if I find something interesting about Sino Biopharmaceutical Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Sino Biopharmaceutical Limited.

Receive notifications about Sino Biopharmaceutical Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.